DailyDoctor Archive Specialties Get app
Back to the 12 October 2026 edition

Research · 03 of 05

Connectivity-guided theta-burst stimulation beat 5-cm targeting in early weeks

Consider this as early evidence for targeting research, not yet a reason to alter the stimulation protocol you use.

Design
Single-centre, randomised, double-blind, three-arm trial
Population
119 analysed adults with major depression or bipolar II depression and at least one antidepressant failure
Primary outcome
Percentage reduction in 17-item Hamilton Depression Rating Scale score at week 2
Effect
Structural-connectivity-guided versus 5-cm: 8.79 percentage points greater (95% CI 2.19 to 15.40), no significant difference at week 12

In a single-centre, double-blind trial, 123 adults aged 18 to 65 with major depression or bipolar II depression and at least one failed antidepressant were randomised to 20 sessions of intermittent theta-burst stimulation over two weeks. Targets were set by the 5-cm scalp rule, by functional connectivity, or by structural connectivity to the subgenual anterior cingulate.

At week 2 the structural-connectivity group had a Hamilton score reduction 8.79 percentage points greater than the 5-cm group (95% CI 2.19 to 15.40). At week 6 both individualised groups were ahead: 12.87 points for structural (6.21 to 19.54) and 9.41 for functional (2.84 to 15.98). By week 12 the differences were no longer significant. No seizures or mania occurred.

This needs replication in more centres, and the lack of difference at week 12 matters for anyone hoping for durable gains. Robotic neuronavigation and tractography are not available in most services in India.

  • Individualised targeting gave faster early improvement than the 5-cm rule.
  • Differences were gone by week 12.
  • No seizures or manic switches were reported in this trial.
  • Requires neuronavigation and imaging, so availability will be limited.
  • Treat it as promising preliminary evidence rather than a reason to change local practice.

Why it matters

It tests whether the long-standing scalp rule is leaving benefit on the table for some patients.

Don't overread it

A single-centre trial with 40 per arm and a primary endpoint at two weeks cannot establish a lasting advantage.

The statistics, in plain English

A Cohen's d of 0.70 to 1.03 is a large standardised difference, but with about 40 people per arm the confidence intervals are wide. The loss of difference at week 12 means the faster response did not translate into a lasting gap.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

psychosisdepressionanxietybipolarsuicide

Tomorrow morning, before your first patient

One edition a day for psychiatry, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app